Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of AVT02 vs Humira in Moderate-to-Severe Chronic Plaque Psoriasis
NCT03849404Phase 3Completed
- Sponsor
- Alvotech
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of AVT02 in plaque psoriasis, sponsored by Alvotech. Started Feb 2019; status: completed.
02
Drugs
AVT02
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03849404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849404.